{"id":981954,"date":"2026-07-15T16:10:53","date_gmt":"2026-07-15T20:10:53","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/surrozen-to-present-at-upcoming-healthcare-investor-conference-7\/"},"modified":"2026-07-15T16:10:53","modified_gmt":"2026-07-15T20:10:53","slug":"surrozen-to-present-at-upcoming-healthcare-investor-conference-7","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/surrozen-to-present-at-upcoming-healthcare-investor-conference-7\/","title":{"rendered":"Surrozen to Present at Upcoming Healthcare Investor Conference"},"content":{"rendered":"
\n

SOUTH SAN FRANCISCO, Calif., July 15, 2026 (GLOBE NEWSWIRE) — Surrozen, Inc.<\/a> (\u201cSurrozen\u201d or the \u201cCompany\u201d) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics to harness the power of Wnt signaling to address the underlying drivers of disease in sight-threatening ophthalmic conditions, today announced that Company management will present at an upcoming healthcare investor conference.<\/p>\n

\n H.C. Wainwright 6<\/strong>
\n
\n th<\/strong>
\n <\/sup>
\n Annual Ophthalmology Virtual Conference on Wednesday, July 22, 2026
<\/strong>Fireside Chat\u00a0at 10:00 AM Pacific Time\/1:00 PM Eastern Time<\/p>\n

Interested parties may access the audio webcast for the conference via the Investors section of the Surrozen website at https:\/\/investors.surrozen.com\/events-presentations\/events-calendar<\/a> beginning at 1:00 PM Eastern Time on July 22, 2026. A replay of the webcast will be archived on the website www.surrozen.com <\/a>for at least 30 days.<\/p>\n

\n About Surrozen
<\/strong>Surrozen\u00a0is a biotechnology company,\u00a0pioneering a new class of\u00a0Wnt-based therapeutics designed to harness the power of Wnt signaling to treat sight-threatening ophthalmic conditions. Built on deep scientific\u00a0expertise\u00a0and a proprietary antibody-engineering platform,\u00a0Surrozen\u00a0develops multifunctional biologics that selectively activate\u00a0Wnt\u00a0signaling in combination with other key disease pathways. Our approach aims to deliver best-in-class, durable therapies that have the potential to transform patient outcomes in some of the most pressing unmet medical needs in ocular diseases. \u00a0For more information, visit www.surrozen.com<\/a>.\u00a0<\/p>\n

\n
\n Forward Looking Statements
<\/em>
\n <\/strong>
\n This press release contains certain forward-looking statements within the meaning of the federal securities laws. Forward-looking statements generally are accompanied by words such as \u201cwill,\u201d \u201cplan,\u201d \u201cintend,\u201d \u201cpotential,\u201d \u201cexpect,\u201d \u201ccould,\u201d or the negative of these words and similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding Surrozen\u2019s discovery, research and development activities, in particular its development plans for its product candidates (including anticipated clinical development plans and timelines, the availability of data, the potential for such product candidates to be used to treat human disease or address unmet needs in serious eye diseases, as well as the potential benefits and potential differentiation from existing therapies of such product candidates); Surrozen\u2019s intention to submit an IND application for SZN-8141 in 2026; and expectations regarding Surrozen\u2019s partnership with Boehringer Ingelheim, including the potential for future success-based development, regulatory, and commercial milestone payments, in addition to mid-single digit to low-double digit royalties on sales. These statements are based on various assumptions, whether or not identified in this press release, and on the current expectations of the management of Surrozen and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on as a guarantee, an assurance, a prediction, or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of Surrozen. These forward-looking statements are subject to a number of risks and uncertainties, including the initiation, cost, timing, progress and results of research and development activities, preclinical and clinical trials with respect to its product candidates and potential future drug candidates; the Company\u2019s ability to fund its preclinical and clinical trials and development efforts, whether with existing funds or through additional fundraising; Surrozen\u2019s ability to identify, develop and commercialize drug candidates; Surrozen\u2019s ability to successfully complete preclinical and clinical studies for its product candidates; the effects that arise from volatility in global economic, political, regulatory and market conditions; and all other factors discussed in Surrozen\u2019s Annual Report on Form 10-K for the year ended December 31, 2025, and Surrozen\u2019s Quarterly Report on Form 10-Q for the quarter ended March 31, 2026 filed with the Securities and Exchange Commission (\u201cSEC\u201d) under the heading \u201cRisk Factors,\u201d and other documents Surrozen has filed, or will file, with the SEC. If any of these risks materialize or our assumptions prove incorrect, actual results could differ materially from the results implied by these forward-looking statements. There may be additional risks that Surrozen presently does not know, or that Surrozen currently believes are immaterial, that could also cause actual results to differ from those contained in the forward-looking statements. In addition, forward-looking statements reflect Surrozen\u2019s expectations, plans, or forecasts of future events and views as of the date of this press release. Surrozen anticipates that subsequent events and developments will cause its assessments to change. However, while Surrozen may elect to update these forward-looking statements at some point in the future, Surrozen specifically disclaims any obligation to do so, except as required by law. These forward-looking statements should not be relied upon as representing Surrozen\u2019s assessments of any date after the date of this press release. Accordingly, undue reliance should not be placed upon the forward-looking statements.<\/em>\n <\/p>\n

\n Investor\/Media Contact:<\/strong>
\n
Email:\u00a0Investorinfo@surrozen.com<\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

SOUTH SAN FRANCISCO, Calif., July 15, 2026 (GLOBE NEWSWIRE) — Surrozen, Inc. (\u201cSurrozen\u201d or the \u201cCompany\u201d) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics to harness the power of Wnt signaling to address the underlying drivers of disease in sight-threatening ophthalmic conditions, today announced that Company management will present at an upcoming healthcare investor conference. H.C. Wainwright 6 th Annual Ophthalmology Virtual Conference on Wednesday, July 22, 2026Fireside Chat\u00a0at 10:00 AM Pacific Time\/1:00 PM Eastern Time Interested parties may access the audio webcast for the conference via the Investors section of the Surrozen website at https:\/\/investors.surrozen.com\/events-presentations\/events-calendar beginning at 1:00 PM Eastern Time on July 22, 2026. A replay of the webcast will be archived on the website www.surrozen.com for at … <\/p>\n

Continue reading “Surrozen to Present at Upcoming Healthcare Investor Conference”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-981954","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nSurrozen to Present at Upcoming Healthcare Investor Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/surrozen-to-present-at-upcoming-healthcare-investor-conference-7\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Surrozen to Present at Upcoming Healthcare Investor Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SOUTH SAN FRANCISCO, Calif., July 15, 2026 (GLOBE NEWSWIRE) — Surrozen, Inc. (\u201cSurrozen\u201d or the \u201cCompany\u201d) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics to harness the power of Wnt signaling to address the underlying drivers of disease in sight-threatening ophthalmic conditions, today announced that Company management will present at an upcoming healthcare investor conference. H.C. Wainwright 6 th Annual Ophthalmology Virtual Conference on Wednesday, July 22, 2026Fireside Chat\u00a0at 10:00 AM Pacific Time\/1:00 PM Eastern Time Interested parties may access the audio webcast for the conference via the Investors section of the Surrozen website at https:\/\/investors.surrozen.com\/events-presentations\/events-calendar beginning at 1:00 PM Eastern Time on July 22, 2026. A replay of the webcast will be archived on the website www.surrozen.com for at … Continue reading "Surrozen to Present at Upcoming Healthcare Investor Conference"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/surrozen-to-present-at-upcoming-healthcare-investor-conference-7\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-15T20:10:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2Mjg2MiM3NzA2NDA2IzIxOTU5MzM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surrozen-to-present-at-upcoming-healthcare-investor-conference-7\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surrozen-to-present-at-upcoming-healthcare-investor-conference-7\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Surrozen to Present at Upcoming Healthcare Investor Conference\",\"datePublished\":\"2026-07-15T20:10:53+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surrozen-to-present-at-upcoming-healthcare-investor-conference-7\\\/\"},\"wordCount\":810,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surrozen-to-present-at-upcoming-healthcare-investor-conference-7\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc2Mjg2MiM3NzA2NDA2IzIxOTU5MzM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surrozen-to-present-at-upcoming-healthcare-investor-conference-7\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surrozen-to-present-at-upcoming-healthcare-investor-conference-7\\\/\",\"name\":\"Surrozen to Present at Upcoming Healthcare Investor Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surrozen-to-present-at-upcoming-healthcare-investor-conference-7\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surrozen-to-present-at-upcoming-healthcare-investor-conference-7\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc2Mjg2MiM3NzA2NDA2IzIxOTU5MzM=\",\"datePublished\":\"2026-07-15T20:10:53+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surrozen-to-present-at-upcoming-healthcare-investor-conference-7\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surrozen-to-present-at-upcoming-healthcare-investor-conference-7\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surrozen-to-present-at-upcoming-healthcare-investor-conference-7\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc2Mjg2MiM3NzA2NDA2IzIxOTU5MzM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTc2Mjg2MiM3NzA2NDA2IzIxOTU5MzM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/surrozen-to-present-at-upcoming-healthcare-investor-conference-7\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Surrozen to Present at Upcoming Healthcare Investor Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Surrozen to Present at Upcoming Healthcare Investor Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/surrozen-to-present-at-upcoming-healthcare-investor-conference-7\/","og_locale":"en_US","og_type":"article","og_title":"Surrozen to Present at Upcoming Healthcare Investor Conference - Market Newsdesk","og_description":"SOUTH SAN FRANCISCO, Calif., July 15, 2026 (GLOBE NEWSWIRE) — Surrozen, Inc. (\u201cSurrozen\u201d or the \u201cCompany\u201d) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics to harness the power of Wnt signaling to address the underlying drivers of disease in sight-threatening ophthalmic conditions, today announced that Company management will present at an upcoming healthcare investor conference. H.C. Wainwright 6 th Annual Ophthalmology Virtual Conference on Wednesday, July 22, 2026Fireside Chat\u00a0at 10:00 AM Pacific Time\/1:00 PM Eastern Time Interested parties may access the audio webcast for the conference via the Investors section of the Surrozen website at https:\/\/investors.surrozen.com\/events-presentations\/events-calendar beginning at 1:00 PM Eastern Time on July 22, 2026. A replay of the webcast will be archived on the website www.surrozen.com for at … Continue reading \"Surrozen to Present at Upcoming Healthcare Investor Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/surrozen-to-present-at-upcoming-healthcare-investor-conference-7\/","og_site_name":"Market Newsdesk","article_published_time":"2026-07-15T20:10:53+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2Mjg2MiM3NzA2NDA2IzIxOTU5MzM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/surrozen-to-present-at-upcoming-healthcare-investor-conference-7\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/surrozen-to-present-at-upcoming-healthcare-investor-conference-7\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Surrozen to Present at Upcoming Healthcare Investor Conference","datePublished":"2026-07-15T20:10:53+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/surrozen-to-present-at-upcoming-healthcare-investor-conference-7\/"},"wordCount":810,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/surrozen-to-present-at-upcoming-healthcare-investor-conference-7\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2Mjg2MiM3NzA2NDA2IzIxOTU5MzM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/surrozen-to-present-at-upcoming-healthcare-investor-conference-7\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/surrozen-to-present-at-upcoming-healthcare-investor-conference-7\/","name":"Surrozen to Present at Upcoming Healthcare Investor Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/surrozen-to-present-at-upcoming-healthcare-investor-conference-7\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/surrozen-to-present-at-upcoming-healthcare-investor-conference-7\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2Mjg2MiM3NzA2NDA2IzIxOTU5MzM=","datePublished":"2026-07-15T20:10:53+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/surrozen-to-present-at-upcoming-healthcare-investor-conference-7\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/surrozen-to-present-at-upcoming-healthcare-investor-conference-7\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/surrozen-to-present-at-upcoming-healthcare-investor-conference-7\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2Mjg2MiM3NzA2NDA2IzIxOTU5MzM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTc2Mjg2MiM3NzA2NDA2IzIxOTU5MzM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/surrozen-to-present-at-upcoming-healthcare-investor-conference-7\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Surrozen to Present at Upcoming Healthcare Investor Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/981954","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=981954"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/981954\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=981954"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=981954"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=981954"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}